Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Autor: Smith CR (AUTHOR), Leon MB (AUTHOR), Mack MJ (AUTHOR), Miller DC (AUTHOR), Moses JW (AUTHOR), Svensson LG (AUTHOR), Tuzcu EM (AUTHOR), Webb JG (AUTHOR), Fontana GP (AUTHOR), Makkar RR (AUTHOR), Williams M (AUTHOR), Dewey T (AUTHOR), Kapadia S (AUTHOR), Babaliaros V (AUTHOR), Thourani VH (AUTHOR), Corso P (AUTHOR), Pichard AD (AUTHOR), Bavaria JE (AUTHOR), Herrmann HC (AUTHOR), Akin JJ (AUTHOR)

Publikováno v: New England Journal of Medicine. 6/9/2011, Vol. 364 Issue 23, p2187-2198. 12p.

cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes.

Autor: Roehle K; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Qiang L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Ventre KS; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Heid D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Lenehan P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Heckler M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Crowley SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Stump CT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Ro G; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Godicelj A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Bhuiyan AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Yang A; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Quiles Del Rey M; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Biary T; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Bruck PT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Tegethoff JF; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nopper SL; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Li J; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Byrne KT; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Pelletier M; Novartis Institute for Biomedical Research, Cambridge, MA 02139, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Stanger BZ; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Akin JJ; Novartis Institute for Biomedical Research, Cambridge, MA 02139, USA., Mancias JD; Division of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Agudo J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA., Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. stephanie_dougan@dfci.harvard.edu.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2021 May 19; Vol. 13 (594).

5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.

Autor: Kapadia SR; Cleveland Clinic, Cleveland, OH, USA. Electronic address: kapadis@ccf.org., Leon MB; Columbia University Medical Center/New York Presbyterian Hospital, New York, NY, USA., Makkar RR; Cedars Sinai Medical Center, Los Angeles, CA, USA., Tuzcu EM; Cleveland Clinic, Cleveland, OH, USA., Svensson LG; Cleveland Clinic, Cleveland, OH, USA., Kodali S; Columbia University Medical Center/New York Presbyterian Hospital, New York, NY, USA., Webb JG; St Paul's Hospital, Vancouver, BC, Canada., Mack MJ; Baylor Scott & White Health, Plano, TX, USA., Douglas PS; Duke Clinical Research Institute/Duke University Medical Center, Durham, NC, USA., Thourani VH; Emory University School of Medicine, Atlanta, GA, USA., Babaliaros VC; Emory University School of Medicine, Atlanta, GA, USA., Herrmann HC; University of Pennsylvania, Philadelphia, PA, USA., Szeto WY; University of Pennsylvania, Philadelphia, PA, USA., Pichard AD; Medstar Washington Hospital Center, Washington, DC, USA., Williams MR; NYU Langone Medical Center, New York, NY, USA., Fontana GP; Lenox Hill Hospital, New York, NY, USA., Miller DC; Stanford University School of Medicine, Department of Cardiovascular Surgery, Falk CV Research Center, Stanford, CA, USA., Anderson WN; independent consultant, Lake Forest, CA, USA., Akin JJ, Davidson MJ; Brigham and Women's Hospital, Boston, MA, USA., Smith CR; Columbia University Medical Center/New York Presbyterian Presbyterian Hospital, New York, NY, USA.

Publikováno v: Lancet (London, England) [Lancet] 2015 Jun 20; Vol. 385 (9986), pp. 2485-91. Date of Electronic Publication: 2015 Mar 15.